Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Begier, Elizabeth"'
Autor:
Begier E; Pfizer Inc, Dublin, Ireland elizabeth.begier@pfizer.com., Pilz A; Pfizer Corporation Austria GmbH, Wien, Austria., Loew-Baselli A; Pfizer Corporation Austria GmbH, Wien, Austria., Harper LR; Pfizer Biopharma Group, Collegeville, Pennsylvania, USA., Stark JH; Pfizer Biopharma Group, Collegeville, Pennsylvania, USA., Bowdery M; University of London, London, UK., Halsby K; Pfizer Ltd, Tadworth, UK., Dzingina M; Pfizer Ltd, Tadworth, UK., Bézay N; Valneva Austria GmbH, Vienna, Austria., Allen KE; Pfizer Biopharma Group, Collegeville, Pennsylvania, USA., Parslow B; University of Exeter, Exeter, UK., Gessner BD; Pfizer Inc, Collegeville, Pennsylvania, USA.
Publikováno v:
BMJ open [BMJ Open] 2023 Dec 10; Vol. 13 (12), pp. e070903. Date of Electronic Publication: 2023 Dec 10.
Autor:
Houben E; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., de Jong H; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Penning-van Beest F; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Kuiper J; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Holthuis E; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Blum M; P95 Pharmacovigilance and Epidemiology, Leuven, Belgium., Skufca J; P95 Pharmacovigilance and Epidemiology, Leuven, Belgium., Riera-Montes M; P95 Pharmacovigilance and Epidemiology, Leuven, Belgium., Gessner BD; Pfizer, Inc., Vaccines Medical Development and Scientific and Clinical Affairs, Collegeville, Pennsylvania, USA., Pilz A; Pfizer Corporation, Vaccines Medical Development and Scientific and Clinical Affairs, Wien, Austria., Vyse AJ; Pfizer UK Ltd., Walton Oaks, United Kingdom., Begier E; Pfizer, Inc., Vaccines Medical Development and Scientific and Clinical Affairs, Collegeville, Pennsylvania, USA., Dzingina M; Pfizer, Inc., Patient Health & Impact, Chief Business Office, Pfizer, New York, New York, USA., Herings R; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.; Department of Epidemiology & Data Science, Amsterdam Public Health Research Institute, Amsterdam UMC, Amsterdam, The Netherlands., Stark JH; Pfizer, Inc., Vaccines Medical Development and Scientific and Clinical Affairs, Collegeville, Pennsylvania, USA.
Publikováno v:
Vector borne and zoonotic diseases (Larchmont, N.Y.) [Vector Borne Zoonotic Dis] 2023 Apr; Vol. 23 (4), pp. 230-236. Date of Electronic Publication: 2023 Jan 27.
Autor:
Paradowska-Stankiewicz I; National Institute of Public Health-National Institute of Hygiene-National Research Institute, Department of Infectious Disease Epidemiology and Surveillance, Warsaw, Poland., Zbrzeźniak J; National Institute of Public Health-National Institute of Hygiene-National Research Institute, Department of Infectious Disease Epidemiology and Surveillance, Warsaw, Poland., Skufca J; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium., Nagarajan A; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium., Ochocka P; National Institute of Public Health-National Institute of Hygiene-National Research Institute, Department of Infectious Disease Epidemiology and Surveillance, Warsaw, Poland., Pilz A; Pfizer Global Medical Affairs, Vaccines, Vienna, Austria., Vyse A; Patient and Health Impact, Pfizer R&D UK LTD, Walton Oaks, United Kingdom., Begier E; Vaccine Clinical Research and Development, Pfizer Inc, Pearl River, New York, USA., Dzingina M; Patient and Health Impact, Pfizer R&D UK LTD, Walton Oaks, United Kingdom., Blum M; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium., Riera-Montes M; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium., Gessner BD; Vaccine Medical Development & Scientific/Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA., Stark JH; Vaccine Medical Development & Scientific/Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA.
Publikováno v:
Vector borne and zoonotic diseases (Larchmont, N.Y.) [Vector Borne Zoonotic Dis] 2023 Apr; Vol. 23 (4), pp. 247-255. Date of Electronic Publication: 2023 Jan 27.
Autor:
Nagarajan A; P95 Epidemiology & Pharmacovigilance, Leuven, Belgium., Skufca J; P95 Epidemiology & Pharmacovigilance, Leuven, Belgium., Vyse A; Vaccines Medical Affairs, Pfizer UK Ltd, Tadworth, United Kingdom., Pilz A; Pfizer Global Medical Affairs, Vaccines, Vienna, Austria., Begier E; Vaccine Clinical Research and Development, Pfizer Inc, Pearl River, New York, USA., Riera-Montes M; P95 Epidemiology & Pharmacovigilance, Leuven, Belgium., Gessner BD; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA., Stark JH; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA.
Publikováno v:
Vector borne and zoonotic diseases (Larchmont, N.Y.) [Vector Borne Zoonotic Dis] 2023 Apr; Vol. 23 (4), pp. 142-155.
Autor:
Skufca J; Epidemiology and Pharmacovigilance, P95, Koning Leopold III Iaan 1, Leuven, Belgium., De Smedt N; Epidemiology and Pharmacovigilance, P95, Koning Leopold III Iaan 1, Leuven, Belgium., Pilz A; Vaccines, Pfizer Corporation Austria, Wien, Vienna, Austria., Vyse A; Vaccines Medical Affairs, Pfizer Ltd, Walton Oaks, Tadworth, United Kingdom., Begier E; Vaccine Clinical Research and Development, Pfizer Inc, Pearl River, New York, USA., Blum M; Epidemiology and Pharmacovigilance, P95, Koning Leopold III Iaan 1, Leuven, Belgium., Riera M; Epidemiology and Pharmacovigilance, P95, Koning Leopold III Iaan 1, Leuven, Belgium., Gessner BD; Vaccines Medical Development and Scientific/Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA., Stark JH; Vaccines Medical Development and Scientific/Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA.
Publikováno v:
Vector borne and zoonotic diseases (Larchmont, N.Y.) [Vector Borne Zoonotic Dis] 2023 Apr; Vol. 23 (4), pp. 256-264. Date of Electronic Publication: 2023 Jan 27.
Autor:
Skufca J; Epidemiology & Pharmacovigilance, P95, Leuven, Belgium., Tran TMP; Epidemiology & Pharmacovigilance, P95, Leuven, Belgium., Brestrich G; Pfizer Pharma GmbH, Berlin, Germany., Pilz A; Pfizer Global Medical Affairs, Vaccines, Vienna, Austria., Vyse A; Vaccines Medical Affairs, Pfizer Ltd., Walton Oaks, United Kingdom., Malerczyk C; Pfizer Pharma GmbH, Berlin, Germany., Dzingina M; Patient Health and Impact, Chief Business Office, Pfizer Inc, New York, New York, USA., Begier E; Vaccine Clinical Research and Development, Pfizer Inc, Pearl River, New York, New York, USA., Blum M; Epidemiology & Pharmacovigilance, P95, Leuven, Belgium., Riera-Montes M; Epidemiology & Pharmacovigilance, P95, Leuven, Belgium., Gessner BD; Vaccines Medical Development & Scientific/Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA., Stark JH; Vaccines Medical Development & Scientific/Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA.
Publikováno v:
Vector borne and zoonotic diseases (Larchmont, N.Y.) [Vector Borne Zoonotic Dis] 2023 Apr; Vol. 23 (4), pp. 237-246.
Autor:
Nagarajan, Archana, Skufca, Jozica, Vyse, Andrew, Pilz, Andreas, Begier, Elizabeth, Riera-Montes, Margarita, Gessner, Bradford D., Stark, James H.
Publikováno v:
Vector-Borne & Zoonotic Diseases; Apr2023, Vol. 23 Issue 4, p142-155, 14p
Autor:
Paradowska-Stankiewicz, Iwona, Zbrzeźniak, Jakub, Skufca, Jozica, Nagarajan, Archana, Ochocka, Paulina, Pilz, Andreas, Vyse, Andrew, Begier, Elizabeth, Dzingina, Mendwas, Blum, Maxim, Riera-Montes, Margarita, Gessner, Bradford D., Stark, James H.
Publikováno v:
Vector-Borne & Zoonotic Diseases; Apr2023, Vol. 23 Issue 4, p247-255, 9p
Autor:
Skufca, Jozica, De Smedt, Nick, Pilz, Andreas, Vyse, Andrew, Begier, Elizabeth, Blum, Maxim, Riera, Margarita, Gessner, Bradford D., Stark, James H.
Publikováno v:
Vector-Borne & Zoonotic Diseases; Apr2023, Vol. 23 Issue 4, p256-264, 9p
Autor:
Houben, Eline, de Jong, Hilda, Penning-van Beest, Fernie, Kuiper, Josephina, Holthuis, Emily, Blum, Maxim, Skufca, Jozica, Riera-Montes, Margarita, Gessner, Bradford D., Pilz, Andreas, Vyse, Andrew John, Begier, Elizabeth, Dzingina, Mendwas, Herings, Ron, Stark, James H.
Publikováno v:
Vector-Borne & Zoonotic Diseases; Apr2023, Vol. 23 Issue 4, p230-236, 7p